Future Fields Stock

Future Fields harnesses insect biotechnology to make sustainable recombinant proteins.

Sign up today and learn more about Future Fields Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Future Fields Stock

Future Fields is committed to producing sustainable components for science through insect biotechnology. Its EntoEngine™ platform is the first to harness the genetic prowess of fruit flies to produce Earth’s most environmentally and economically sustainable biomolecules. Founded in 2018, Future Fields is headquartered in Edmonton, Canada and proudly backed by marquee venture capital firms and investors from Silicon Valley and beyond. Learn more about how Future Fields is enabling great science at https://futurefields.io/.

Funding History

February 2020$600K
August 2020$125K
February 2021$2.2M
February 2023$15.1M
February 2023$5.0M


Co-Founder & CEO

Matthew Anderson-Baron

Co-Founder and COO

Jalene Anderson-Baron

Board Member

Kira Noodleman


Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: